Philip Morris
Synthesis of Tobacco Additives 810701 - 810731
Fields
- Author
- Seeman, J.I.
- Alias
- PRO2500
- Type
- REPT, REPORT, OTHER
- BIBL, BIBLIOGRAPHY
- Area
- CENTRAL FILES/DATABASE
- Site
- R100
- Request
- Stmn/R1-004
- Stmn/R1-071
- Stmn/R1-145
- Stmn/R1-147
- Stmn/R1-149
- Named Person
- Bassfield, R.
- Wooten, J.
- Master ID
- 2022151336/1407
- 2022151336-1407 Monthly Progress Reports Period Covered 810701 - 810731
- 2022151339-1340 Analytical Research
- 2022151341 Mechanism for Smoke Formation 810701 - 810731
- 2022151342-1343 Cigarette and Tobacco Measurement Methods 810700
- 2022151344-1345 Improved Semiworks Operations 810700
- 2022151346-1347 Entomological Research 810701 - 810731
- 2022151348-1350 Reconstituted Tobacco Development 810709 - 810806
- 2022151351-1352 Modified Smoking Materials 810701 - 810731
- 2022151353-1355 Smoker Psychology 810701 - 810731
- 2022151356 Filtration Physics 810701 - 810731
- 2022151357-1358 Cigarette Making Technology 810701 - 810731
- 2022151359-1360 Tobacco Physics 810701 - 810731
- 2022151361-1362 Physical and Chemical Properties of Tobacco 870701 - 870731
- 2022151363-1364 Tobacco Microstructure 810701 - 810731
- 2022151365-1367 Tobacco Processing 810701 - 810731
- 2022151368-1369 Expanded Tobacco - Process Improvement 810701 - 810731
- 2022151370-1371 Biochemical Modification of Tobacco 810701 - 810731
- 2022151372-1373 Microbial Technology 810701 - 810731
- 2022151374-1375 New Products 810700
- 2022151376 Filter Development 810700
- 2022151377 Applied Technology 810701 - 810731
- 2022151378 Flavor Development 810701 - 810731
- 2022151379-1380 Flavor Development 810701 - 810731
- 2022151381 Flavor Component Evaluation 810701 - 810731
- 2022151384-1386 Nuclear and Radiochemistry of Smoke 810701 - 810731
- 2022151387-1388 Botanical Investigations 810701 - 810731
- 2022151389-1390 Flavor - Release Chemistry 810701 - 810731
- 2022151391-1393 Synthesis of Flavorants 810700
- 2022151394-1395 Chemistry and Isolation of Tobacco Constituents 810701 - 810731
- 2022151396-1397 Smoke Studies 810700
- 2022151398-1399 Brand Modifications 810700
- 2022151400-1402 Biological Effects of Smoke 810701 - 810731
- 2022151403-1406 Smoke Condensate Studies 810701 - 810731
Related Documents:
Document Images
CHARGE NUMBER: 2500
PROJECT TITLE: Synthesis of Tobacco Additives
PROJECT LEADER: Jeffrey I. Seeman
PERIOD COVERED: July 1- 31, 1981
DATE OF REPORT: August 10, 1981
I. Flavor Chemistry
We are in the process of preparing a series of 2,6-dialkylpyridines
for odor/flavor evaiuati.on. These compounds will be of significant interest
because the additi'on of bulky substituents near the pyrfidine nitrogen has
been observed to significantliy effect odor, e.g_., for hilghly substituted
pyridines, there remains very little "pyridine-like" odor. 2-siec-Butyl-6-
methylpyri.dine was obtained by alkylating 2,6-lutidine with isopropyl bromide/
phenyllithium. Purification of the materi.al was achieved by a combination
of careful fractional distillation and Chromatotron chromotography. We are
in the process of synthesizing additional compounds in this series.'
A draft of a patent application for a process of preparing acylpyrazines
has been completed.2'3
II. Nicotine Chemistry
cis- and trans-4' -Methyinicotines have been purified by careful
Chromatotron chromotography.," thereby completing the isolation of the series
of monomethylnicotines. These compounds, which are currently undergoing
pharmacological testing, have been examined by NMR spectroscopys at high ..
magnettc field C36Q MHz and 400 MHz). Spectral data-amenable to line shape
analysis, is_now in hand, thereby allowing a goa1of establishing the
pyrrolidine ring conformations of these isomeric compounds. This structural
information is important in that conformation has been related to pharmaco-
logical activity for numerous compounds.
Zn collaboration with Ron Bassfield, a procedure has been developed
which quantitates the optical purity of nicotine. This lanthanide shift
technique has been applied to 5-methyl and 6-methylnicotines. Characterization
of optical purity is essential in evaluating the pharmacological activiti.es of
chi.ral compounds, in that enantiomers and diastereomers usually have quiite
different activity profiles."
One_of the.important aspects of pharmacology is the i,solation, identi-
fication and characterization of the pertinent receptor(s). For nicotine
receptor isolation, the preparation of high specific labeled nicotine would
be a significant asset. We have begun to evaluate a number of possible

-2-
C
r.
syntheses of optically pure, "hot" 1-nicotine. Samples of 5'-cyanonicotine
have'been successfully reduced to nicotine with both hydrogen gas and
deuterium gas in the presence of Pd/C as catalyst. We are currently re-
fining and improving these procedures which will eventually be used with
carrier-free triti.um (under contract).6
To elucidate the ring-ring conformational features of nicotine, we
have been examining the rotational properties of nicotine analogues with
Jan Wooten. cis-3`-Methylnicotine-l'-ds, 2,4-dimethylnicotine-l`-d3 and
2,4-dimethylnicoti.ne have been synthesized for these studies.s
We have completed the syntheses of optically pure 6-isopropyl-and
6-ethylnlcotine via the free radial alkylation routes and have obtained
high optiical' rotat ns for these compaunds.1
We are continuing to have success in the preparation of additional
bridged nicotinoids. 3-Cyanoacetamide-2-cyclohexenone was cyclized to
2,3,5,6,7,8-hexahydro-3, 8-dfoxo-4-isoquinoline carbonitrile (74% yield)
and decyanated with 48% HBr (42%'yield) to 2,3,5,6,7,8-hexahydro-3,8-
di'oxoisoquinoline, a precursor of the quinolone required.°
III. RPLC Applications
A series of substituted pyridines was run on HPLC and their relative
retention volumes correlated excellently with their rate constants of
iodomethylation. This novel reactivity-HPLC relationship will assist us
in developing additional separation schemes for heteroaromatic compounds in
both the nicotine and flavor/odor fields.'
Six nicotine reaction mixtures were purified by HPLC and optical
rotations were obtained for all the isolated analogues. These studies
now serve both as the state-of-the-art models for nicotine purification
and also provide us the data for understanding the mechanism of these
nicotine reactions.'
1. Clawson, L. 7659
2. Southwick, R. 7447
3. With D. Williams
4. Chavdarian, C. 7594
5. With D. Cox
6. Secor, H. V. 7566
7. Howe, D. 7575
